脑机接口重大利好，概念股直线飙涨近10%

Core Viewpoint - The article highlights the recent surge in brain-computer interface (BCI) concept stocks, particularly following the approval of a groundbreaking BCI medical device by the National Medical Products Administration of China, which is set to enhance the quality of life for patients with quadriplegia [1][4]. Group 1: Market Reaction - On March 13, brain-computer interface concept stocks experienced significant movement, with companies like Innovation Medical and Sanbo Brain Science seeing their shares rise nearly 10% [1]. - Innovation Medical's stock price increased by 5.55%, closing at 31.40, with a trading volume of 640,200 shares and a total transaction amount of 1.96 billion [2]. Group 2: Product Approval and Features - The National Medical Products Administration approved the registration application for a novel implanted brain-computer interface system by Borekan Medical Technology, marking the first global launch of such a medical device [4]. - The product includes components such as an implanted brain-computer interface, brain electrode kit, signal transceiver, pneumatic glove, surgical tool kit, and software for decoding brain signals and clinical management [4]. - It is designed for patients aged 18 to 60 with cervical spinal cord injuries, specifically those classified as A to C on the ASIA scale, who have stable conditions for at least six months and cannot perform hand grasping [4].